Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Shares of Atkore Inc (NYSE:ATKR) rose sharply in pre-market trading, after the company posted upbeat third-quarter results and agreed to be acquired by Prysmian for $95.00 per share in all-cash deal.

Atkore reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.56 per share. The company reported quarterly sales of $794.800 million which beat the analyst consensus estimate of $761.233 million.

Atkore shares jumped 26.1% to $92.00 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Universe Pharmaceuticals Inc (NASDAQ:UPC) gained 214.2% to $9.93 in pre-market trading after declining 9% on Friday.
• AiRWA Inc (NASDAQ:YYAI) rose 73.3% to $0.21 in pre-market trading after dipping 29% on Friday.
• Reitar Logtech Holdings Ltd (NASDAQ:RITR) rose 69.3% to $0.097 in pre-market trading after declining 8% on Friday.
• Focus Universal Inc (NASDAQ:FCUV) rose 53.3% to $17.79 in pre-market trading. Focus Universal shares jumped 517% on Friday after the company announced the launch of its Deterministic AI Forms Auto-Populate Engine, an enterprise document platform designed to transform repetitive manual document processing into fully autonomous electronic workflows.
• Singularity Future Technology Ltd (NASDAQ:SGLY) shares rose 35% to $7.06 in pre-market trading after gaining 13% on Friday.
• FingerMotion Inc (NASDAQ:FNGR) gained 28.6% to $0.35 in pre-market trading after rising 14% on Friday.
• Alarum Technologies Ltd – ADR (NASDAQ:ALAR) rose 12.5% to $1.89 in pre-market trading.
• Ferguson Enterprises Inc (NYSE:FERG) gained 8% to $253.00 in pre-market trading. Ferguson Enterprises will replace Electronic Arts in the S&P 500 effective prior to the opening of trading on Aug. 5.
• Bristol-Myers Squibb Co (NYSE:BMY) rose 7% to $69.75 in pre-market trading. AstraZeneca Plc (NASDAQ:AZN) is reportedly in discussions with Bristol Myers Squibb to merge, potentially forming a pharmaceutical giant valued at nearly $400 billion.

Losers

• Kandal M Venture Ltd (NASDAQ:FMFC) tumbled 40.3% to $0.31 in pre-market trading after surging 141% on Friday.
• PowerCompute Inc (NASDAQ:PWCM) fell 29.8% to $1.49 in pre-market trading after gaining 10% on Friday.
• Site Centers Corp (NYSE:SITC) fell 23.2% to $3.29 in pre-market trading.
• JIADE Ltd (NASDAQ:JDZG) declined 26.6% to $4.41 in pre-market trading after dipping 88% on Friday.
• Mangoceuticals Inc (NASDAQ:MGRX) fell 22.8% to $0.43 in pre-market trading after jumping 90% on Friday. The company recently announced a definitive business combination with Nuclea Energy Inc., a developer of the Morpheus lead-cooled microreactor.
• Inno Holdings Inc (NASDAQ:INHD) fell 22.4% to $13.97 in pre-market trading after dipping 54% on Friday.
• Masonglory Ltd (NASDAQ:MSGY) fell 19.7% to $0.24 in pre-market trading after declining 9% on Friday.
• Addentax Group Corp (NASDAQ:ATXG) fell 17.5% to $2.91 in pre-market trading.
• Apnimed Inc (NASDAQ:APMD) fell 9.4% to $22.68 in pre-market trading after surging 56% on Friday.
• Alvotech SA (NASDAQ:ALVO) fell 7.3 to $3.82 in pre-market trading after gaining 15% on Friday. The company, last week, announced the FDA has closed its inspection of its Reykjavik manufacturing facility, classifying the site as Voluntary Action Indicated.

Photo via Shutterstock